Aging and luteinizing hormone effects on reactive oxygen species production and DNA damage in rat leydig cells

Biology of Reproduction

Volumn 88, Issue 4, 2013, Pages

  Beattie, Matthew C ^a   Chen, Haolin ^a   Fan, Jinjiang ^b   Papadopoulos, Vassilios ^b   Miller, Paul ^a   Zirkin, Barry R ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Aging; DNA damage; DNA repair; Leydig cell; ROS

Indexed keywords

LUTEINIZING HORMONE; REACTIVE OXYGEN METABOLITE;

AGED; ANIMAL CELL; ARTICLE; CELL AGING; CELL ISOLATION; CELL STIMULATION; CELL STRESS; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; LEYDIG CELL; MACROMOLECULE; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

AGE FACTORS; AGING; ANIMALS; CELLS, CULTURED; DNA DAMAGE; GENE EXPRESSION; GLUTATHIONE; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; MODELS, BIOLOGICAL; RATS; RATS, INBRED BN; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 84877013644     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.107052     Document Type: Article

References (49)

1. Vermeulen A, Kaufman JM. Ageing of the hypothalamo-pituitarytesticular axis in men. Horm Res 1995; 43:25-28.
2. Chen H, Hardy MP, Huhtaniemi I, Zirkin BR. Age-related decreased Leydig cell testosterone production in the Brown Norway rat. J Androl 1994; 15:551-557.
3. Puett D, Li Y, DeMars G, Angelova K, Fanelli F. A functional transmembrane complex: The luteinizing hormone receptor with bound ligand and G protein. Mol Cell Endocrinol 2007; 260-263:126-136.
4. Rone M, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: Role of protein-protein interactions and implications in disease states. Biochim Biophys Acta 2009; 1791:646-658.
5. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000; 25:502-508.
6. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial p450 systems in steroidogenic cells. Drug Metab Rev 2006; 38:171-196.
7. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry 2005; 70:246-264.
8. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Nat Acad Sci U S A 1993; 90:7915-7922.
9. Rebrin I, Sohal RS. Pro-oxidant shift in glutathione redox state during aging. Adv Drug Deliv Rev 2008; 60:1545-1552.
10. Luo L, Chen H, Trush MA, Show MD, Anway MD, Zirkin BR. Aging and the brown Norway rat Leydig cell antioxidant defense system. J Androl 2006; 27:240-247.
11. Cao L, Leers-Sucheta S, Azhar S. Aging alters the functional expression of enzymatic and non-enzymatic anti-oxidant defense systems in testicular rat Leydig cells. J Steroid Biochem Mol Biol 2004; 88:61-67.
12. Chen H, Cangello D, Benson S, Folmer J, Zhu H, Trush MA, Zirkin BR. Age-related increase in mitochondrial superoxide generation in the testosterone-producing cells of Brown Norway rat testes: relationship to reduced steroidogenic function? Exp Gerontol 2001; 36:1361-1373.
13. Lee SY, Gong EY, Hong CY, Kim KH, Han JS, Ryu JC, Chae HZ, Yun CH, Lee K. ROS inhibit the expression of testicular steroidogenic enzyme genes via the suppression of Nur77 transactivation. Free Radic Biol Med 2009; 47:1591-1600.
14. Yacobi K, Tsafriri A, Gross A. Luteinizing hormone-induced caspase activation in rat preovulatory follicles is coupled to mitochondrial steroidogenesis. Endocrinology 2007; 148:1717-1726.
15. Vega M, Carrasca I, Castillo T, Troncoso JL, Videla IA, Devoto L. Functional luteolysis in respons.e to hydrogen peroxide in human luteal cells. Endocrinology 1995; 147:177-182.
16. Chen H, Zirkin BR. Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging. Proc Nat Acad Sci U S A 1999; 96:14877-14881.
17. Klinefelter GR, Hall PF, Ewing LL. Effect of luteinizing hormone deprivation in situ on steroidogenesis of rat Leydig cells purified by a multistep procedure. Biol Reprod 1987; 36:769-783.
18. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002; 31:19-20.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci U S A 2005; 102:15545-15550.
20. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57.
21. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 1981; 108:88-95.
22. Singh N, McCoy M, Tice R, Schneider E. A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175:184-191.
23. Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 2002; 54:527-559.
24. Cohen M, Reichenstein M, Everts-van der Wind A, Heon-Lee J, Shani M, Lewin H, Weller JI, Ron M, Seroussi E. Cloning and characterization of FAM13A1-a gene near a milk protein QTL on BTA6: evidence for population-wide linkage disequilibrium in Israeli Holsteins. Genomics 2004; 84:374-383.
25. Rao G, Katki K, Madamanchi N, Wu Y. JunB forms the majority of AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and g protein-coupled receptor agonist in smooth muscle cells. J Biol Chem 1999; 274:6003-6010.
26. Swaminathan S. Post-replication repair: ubiquitin throws the switch. Nat Cell Biol 2004; 6:578.
27. Song KH, Park JI, Lee MO, Soh J, Lee K, Choi HS. LH induces orphan nuclear receptor Nur77 gene expression in testicular Leydig cells. Endocrinology 2001; 142:5116-5123.
28. Fernandez PM, Brunel F, Jimenez MA, Saez JM, Cereghini S, Zakin MM. Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endocrinology 2000; 141:2392-2400.
29. Volakakis N, Kadkhodai B, Joodmardi E, Wallis K, Panman L, Silvaggi J, Spiegelman BM, Perlmann T. NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection. Proc Nat Acad Sci U S A 2010; 107:12317-12322.
30. Luo C, Urgard E, Vooder T, Metspalu A. The role of COX-2 and Nrf2/ARE in ani-inflammation and antioxidative stress: aging and anti-aging. Med Hypotheses 2011; 77:174-178.
31. Matthew EM, Hart LS, Astrinidis A, Navaraj A, Dolloff NG, Dicker DT, Henske EP, El-Deiry WS. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions. Cell Cycle 2009; 8:4168-4175.
32. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH. Dexras1: A G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000; 28:183-193.
33. Oppermann U. Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinine-reducing enzymes and their role in physiology. Annu. Rev. Pharmacol Toxicol 2007; 47:293-322.
34. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Feinstein E. Identification of a novel hypoxiainducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22:2283-2293.
35. Li L, Hung AC, Porter AG. Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxideinduced apoptosis of neuroblastoma cells. Cell Death Differ 2008; 15:879-888.
36. Park WR, Nakamura Y. p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway. Cancer Res 2005; 65:1197-1206.
37. Chen H, Pechenino AS, Liu J, Beattie MC, Brown T, Zirkin B. Effect of glutathione depletion on Leydig cell steroidogenesis in young and old Brown Norway rats. Endocrinology 2008; 149(5):2612-2619.
38. Haider SG. Cell biology of the Leydig cells in the testis. Int Rev Cytol 2004; 233:181-241.
39. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17:1195-214.
40. Chen H, Zhou L, Lin CY, Beattie MB, Liu J, Zirkin BR. Effect of glutathione redox state on Leydig cell susceptibility to acute oxidative stress. Mol Cell Endocrinol 2010; 323:147-154.
41. Myers RB, Abney TO. The effects of reduced O2 and antioxidants on steroidogenic capacity of cultured rat Leydig cells. J Steroid Biochem 1988; 31:305-309.
42. Perkins LM, Hall PF, Payne AH. Testosterone-enhanced oxygen-mediated degradation of P-450(17) alpha in mouse Leydig cell cultures. Endocrinology 1988; 122:2257-2264.
43. Georgiou M, Perkins LM, Payne AH. Steroid synthesis-dependent, oxygen-mediated damage of mitochondrial and microsomal cytochrome P-450 enzymes in rat Leydig cell cultures. Endocrinology 1987; 121:1390-1399.
44. Klinefelter GR, Ewing LL. Maintenance of testosterone production by purified adult rat Leydig cells for 3 days in vitro. In Vitro Cell Dev Biol 1989; 25:283-8.
45. Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Péranzi G, Yao ZX, Maccario J, Lacapère JJ, Papadopoulos V. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 2003; 42:4506-4519.
46. Aggarwal A, Misro MM, Maheshwari A, Sehgal N. Differential modulation of apoptotic gene expression by N-acetyl-L-cysteine in Leydig cells stimulated persistently with hCG in vivo. Mol Cell Endocrinol 2012; 348:155-164.
47. Aggarwal A, Misro MM, Maheshwari A, Sehgal N, Nandan D. Nacetylcysteine counteracts oxidative stress and prevents hCG-induced apoptosis in rat Leydig cells through down regulation of caspase-8 and JNK. Mol Reprod Dev 2010; 77:900-909.
48. Aggarwal A, Misro MM, Maheshwari A, Sehgal N, Nandan D. Adverse effects associated with persistent stimulation of Leydig cells with hCG in vitro. Mol Reprod Dev 2009; 76:1076-1083.
49. Tai P, Ascoli M. Reactive oxygen species (ROS) play a critical role in the cAMP-induced activation of Ras and the phosphorylation of ERK1/2 in Leydig cells. Mol Endocrinol 2011; 25:885-893.